Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | FL115 |
| Synonyms | |
| Therapy Description |
FL115 is a long-acting form of IL-15 comprising a IL-15 variant complexed with a soluble IL-15 receptor alpha Fc domain, which potentially induces activation of NK and memory T cells and enhances antitumor immune response (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| FL115 | FL 115|FL-115|L-15(N72D)/IL-15Ra-sFc fusion protein complex | FL115 is a long-acting form of IL-15 comprising a IL-15 variant complexed with a soluble IL-15 receptor alpha Fc domain, which potentially induces activation of NK and memory T cells and enhances antitumor immune response (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06130722 | Phase I | FL115 | First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study | Recruiting | USA | 0 |